Company intelligence / Profile preview

Synchronicity

South San Francisco, California, USA

Ownership: Private
Development stage: Other

Overview

Synchronicity Pharma was a biotechnology company focused on developing small molecule therapeutics that modulate the circadian clock to treat metabolic and oncologic diseases. Founded on the premise that disruptions in circadian rhythms are linked to various chronic conditions, the company aimed to restore metabolic balance through targeted pharmacological intervention. Its research primarily targeted core clock proteins to address indications such as Type 2 diabetes and NASH. Despite early-stage venture backing, the company is no longer active in the drug development space.

Therapeutic areas: OncologyEndocrinologyGastroenterologyMetabolic Disorders
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Synchronicity.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synchronicity.

Explore the full profile